MinichMacGregor Wealth Management LLC Buys New Shares in Church & Dwight Co., Inc. (NYSE:CHD)

MinichMacGregor Wealth Management LLC purchased a new position in shares of Church & Dwight Co., Inc. (NYSE:CHD) during the 1st quarter, Holdings Channel.com reports. The fund purchased 68,770 shares of the company’s stock, valued at approximately $7,571,000. Church & Dwight comprises approximately 1.7% of MinichMacGregor Wealth Management LLC’s holdings, making the stock its 21st biggest holding.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Church & Dwight by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 30,691,064 shares of the company’s stock valued at $3,213,661,000 after buying an additional 193,602 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Church & Dwight by 19.4% in the 4th quarter. JPMorgan Chase & Co. now owns 7,336,046 shares of the company’s stock valued at $768,157,000 after acquiring an additional 1,190,154 shares during the period. Geode Capital Management LLC lifted its holdings in Church & Dwight by 2.6% during the 4th quarter. Geode Capital Management LLC now owns 5,915,390 shares of the company’s stock valued at $617,794,000 after purchasing an additional 148,234 shares during the last quarter. Stifel Financial Corp boosted its position in Church & Dwight by 0.5% during the fourth quarter. Stifel Financial Corp now owns 4,316,414 shares of the company’s stock worth $451,975,000 after purchasing an additional 20,887 shares during the period. Finally, Norges Bank acquired a new position in shares of Church & Dwight in the fourth quarter valued at $318,532,000. 86.60% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CHD has been the topic of several research analyst reports. Cowen lowered shares of Church & Dwight from a “buy” rating to a “hold” rating in a research report on Tuesday, May 6th. Wall Street Zen raised shares of Church & Dwight from a “sell” rating to a “hold” rating in a report on Saturday. Royal Bank Of Canada upgraded shares of Church & Dwight from a “sector perform” rating to an “outperform” rating and raised their price objective for the stock from $100.00 to $114.00 in a research report on Monday, June 2nd. Barclays decreased their target price on Church & Dwight from $94.00 to $84.00 and set an “underweight” rating on the stock in a research report on Friday, May 2nd. Finally, JPMorgan Chase & Co. dropped their price target on Church & Dwight from $106.00 to $98.00 and set an “underweight” rating for the company in a report on Friday, April 11th. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, Church & Dwight has an average rating of “Hold” and a consensus price target of $108.67.

Insider Activity

In other Church & Dwight news, Director Penry W. Price sold 14,660 shares of Church & Dwight stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of $93.13, for a total value of $1,365,285.80. Following the transaction, the director now owns 27,043 shares in the company, valued at $2,518,514.59. The trade was a 35.15% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Michael Read bought 3,000 shares of the stock in a transaction on Friday, May 9th. The shares were acquired at an average cost of $92.07 per share, with a total value of $276,210.00. Following the purchase, the executive vice president now owns 5,505 shares of the company’s stock, valued at approximately $506,845.35. This represents a 119.76% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders sold 50,575 shares of company stock worth $4,910,586. 2.00% of the stock is currently owned by corporate insiders.

Church & Dwight Trading Up 0.6%

Shares of NYSE:CHD opened at $96.42 on Friday. The company has a market capitalization of $23.75 billion, a P/E ratio of 41.38, a P/E/G ratio of 3.87 and a beta of 0.52. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.95 and a quick ratio of 1.43. The business’s 50 day simple moving average is $97.77 and its 200 day simple moving average is $103.46. Church & Dwight Co., Inc. has a 1 year low of $90.99 and a 1 year high of $116.46.

Church & Dwight (NYSE:CHD) last released its earnings results on Thursday, May 1st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. The company had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.52 billion. Church & Dwight had a return on equity of 19.28% and a net margin of 9.52%. Church & Dwight’s quarterly revenue was down 2.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.96 EPS. On average, research analysts anticipate that Church & Dwight Co., Inc. will post 3.7 EPS for the current fiscal year.

Church & Dwight Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Shareholders of record on Thursday, May 15th were issued a $0.295 dividend. This represents a $1.18 annualized dividend and a yield of 1.22%. The ex-dividend date was Thursday, May 15th. Church & Dwight’s dividend payout ratio is currently 50.64%.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.